Table 2.
RCT | Country | Age (Years) (Minimum-Maximum) | Physical Activity Level * | Trainings per Week (Mean) ** | Body Composition Measurement Method | Dose of WP (g·kg−1) | Nutritional Intervention | n (M:F) |
---|---|---|---|---|---|---|---|---|
Burke et al. [31] | Canada | 18–31 | Regular | 4 | DXA | 1.2 | WPI | 10:0 |
Maltodextrin | 5:0 | |||||||
Cribb et al. [32] | Australia | 18–31 | Regular | 4 | DXA | 1.28 | WPI | 5:0 |
Non-specific carbohydrate | 7:0 | |||||||
Herda et al. [33] | USA | 18.5–23.9 | Regular | 3 | Hydrostatic Weighing | 0.25 | WPC | 22:0 |
Maltodextrin | 21:0 | |||||||
Hulmi et al. [34] | Finland | 33.1–35.7 | Sporadic | 2.5 | DXA | 0.35 | WPC | 22:0 |
Maltodextrin | 21:0 | |||||||
Lockwood et al. [35] | USA | 18–35 | Regular | 2 | DXA | 0.37 | WPC | 13:0 |
Dextrose | 15:0 | |||||||
WPH | 13:0 | |||||||
Dextrose | 15:0 | |||||||
Naclerio et al. [36] | USA | 22–34 | Regular | 5 | Plethysmography | 0.26 | WPI | 8:0 |
Non-specific carbohydrate | 8:0 | |||||||
Naclerio et al. [37] | USA | 36.4–54.2 | Athlete | 3 | Plethysmography | 0.24 | WPI | 8:0 |
Non-specific carbohydrate | 8:0 | |||||||
Reidy et al. [38] | USA | 18–30 | Sporadic | 3 | DXA | 0.27 | WPI | 22:0 |
Maltodextrin | 23:0 | |||||||
Taylor et al. [39] *** | USA | 18–24 | Athlete | 4 | DXA | 0.36 | WPC | 0:8 |
Maltodextrin | 0:6 | |||||||
Volek et al. [40] *** | USA | 19.1–26.9 | Sporadic | 2.5 | DXA | 0.24 | WPC | 13:6 |
Maltodextrin | 13:9 |
* According to the criteria adopted for individuals prior to their entry into each study. ** During the application of the intervention protocol for all groups. *** Study included in qualitative analysis only. M: male. F: female. RCT: Randomized clinical trial. WP: whey protein. WPC: concentrate whey protein. WPH: hydrolyzed whey protein. WPI: isolated whey protein.